Darwin Wealth Management
VRTX icon

Darwin Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Darwin Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.5K Buy
+43
New +$22K 0.01% 488
2020
Q3 		– Sell
-10,062
Closed -$2.92M – 175
2020
Q2 		$2.92M Buy
10,062
+10,036
+38,600% +$2.72M 0.74% 48
2020
Q1 		$6K Buy
+26
New +$5.96K ﹤0.01% 582

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Darwin Wealth Management's VRTX Position: Q3 2026 in Review

Darwin Wealth Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 43 shares worth $22.5K. The stake represents 0.01% of the portfolio and ranks #488 among its holdings. This is a return to the name: Darwin Wealth Management previously reported a position in VRTX as recently as Q2 2020.

Darwin Wealth Management first reported a position in VRTX in Q1 2020 and has held it in 3 quarters since. The position peaked at $2.92M in Q2 2020. 1,161 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Darwin Wealth Management held 43 shares of Vertex Pharmaceuticals worth $22.5K as of Q3 2026.
  • Vertex Pharmaceuticals was a new Darwin Wealth Management position in Q3 2026.
  • Vertex Pharmaceuticals made up 0.01% of Darwin Wealth Management's portfolio in Q3 2026, its #488 holding.
  • Darwin Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 3 quarters since.
  • Darwin Wealth Management's Vertex Pharmaceuticals position peaked at $2.92M in Q2 2020.
  • 1,161 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Darwin Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.